Showing results (11-20 of 560) with videos related to
Sort By:
Pageof 56
Medical Oncology (Northwood, London, England)|April 13, 2016
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancerDaniel A Goldstein, Kavya Krishna, Christopher R Flowers, et al.Expert Review of Vaccines|June 5, 2007
BiovaxID idiotype vaccination: active immunotherapy for follicular lymphomaChristopher R FlowersLeukemia & Lymphoma|November 11, 2016
Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patientsAshish Rai, Loretta J Nastoupil, Jessica N Williams, et al.The Oncologist|June 9, 2017
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness AnalysisDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.Pharmacoeconomics|June 26, 2004
The role of cost-effectiveness analysis in the era of pharmacogenomicsChristopher R Flowers, David VeenstraCurrent Oncology (Toronto, Ont.)|May 27, 2025
Patient-Reported Outcome Measures (PROMS) in LymphomaNeha Akkad, Christopher R FlowersClinical Lymphoma, Myeloma & Leukemia|December 16, 2010
A decade of progress in lymphoma: advances and continuing challengesChristopher R Flowers, James O ArmitageBlood|January 9, 2016
Identifying risk factors for B-cell lymphomaChristopher R Flowers, Christine F SkibolaHematology. American Society of Hematology. Education Program|February 20, 2015
Optimal disease surveillance strategies in non-Hodgkin lymphomaJonathon B Cohen, Christopher R FlowersExpert Review of Hematology|April 22, 2016
B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune diseaseJean L Koff, Christopher R FlowersPageof 56